Discontinuation report CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML
Report ID | 1685 |
Drug Identification Number | 02163683 |
Brand name | CEFZIL POWDER FOR ORAL SUSPENSION-250MG/5ML |
Common or Proper name | Cefprozil |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CEFPROZIL |
Strength(s) | 250mg |
Dosage form(s) | Powder for solution |
Route of administration | oral |
Packaging size | 1 BTL x 100ml |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-08-31 |
Actual discontinuation date | 2017-08-23 |
Remaining supply date | 2017-08-23 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | 125mg/5ml 75ml and 100ml will be available until the end of Dec. 2017. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v3 | 2017-04-03 | English | Compare |
v4 | 2017-04-03 | French | Compare |
v5 | 2017-06-02 | English | Compare |
v6 | 2017-06-02 | French | Compare |
v7 | 2017-06-19 | English | Compare |
v8 | 2017-06-19 | French | Compare |
v9 | 2017-07-29 | English | Compare |
v10 | 2017-07-29 | French | Compare |
v11 | 2017-08-25 | English | Compare |
v12 | 2017-08-25 | French | Compare |
Showing 1 to 12 of 12